Germany: Third party interventions to ex parte proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: Third party interventions to ex parte proceedings

In a decision (BGH X ZB 4/14, "Verdickerpolymer II"), the German Federal Court of Justice (BGH) has resolved the question of third party interventions to ex parte proceedings. The BGH found that there is no legal basis for third party interventions to ex parte proceedings of the patent proprietor requesting reinstatement even when the third party is sued for infringement of the patent in suit.

The German part of European patent EP 682 094, maintained in amended form after opposition proceedings, lapsed in Germany because the proprietor failed to pay the publication fee and provide a German translation of the amended patent within the legal deadlines. The patent proprietor requested reinstatement and a third party being sued for infringement of the patent in suit requested intervention to the reinstatement proceedings.

Section 59(2) PatG provides a legal basis for third party interventions to inter-partes opposition proceedings in the case of pending infringement or declaratory proceedings. Section 44(2) PatG explicitly excludes third party interventions to ex-parte grant proceedings.

The BGH found that the lack of a provision concerning a third party intervention to ex-parte proceedings if the third party is sued for infringement of the patent in suit is not considered as an unplanned legal loophole. The restrictive character of the provisions for third party interventions indicates a conclusive nature that cannot be generalised. It is emphasised that reinstatement proceedings are ancillary proceedings conducted in the course of main proceedings and if third party interventions to main proceedings are only allowed under exceptional circumstances similar hurdles must apply for associated ancillary proceedings.

With respect to decision BGH X ZB 26/70 "Hopfenextrakt", wherein an opponent was allowed to participate in reinstatement proceedings, it is emphasised that this decision has been issued under the previous law and is based on the prerequisite that opposition proceedings are conducted as part of grant proceedings. The decision is not considered applicable when opposition proceedings and grant proceedings are independent from each other.

It has been clarified that a third party intervention to ancillary proceedings is only allowable if the third party is involved in the corresponding main proceedings. Furthermore, the existing provisions on third party interventions are considered conclusive.

Tim Pust


Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

Home-working and grace periods at IP offices have been announced, while Managing IP understands Iran’s IP office is out of service
With INTA 2026 just two months away, London-based IP practitioners offer tips on making the most out of the city
New platform, which covers SEPs for the Wi-Fi 6 and Wi-Fi 7 standards, includes 10 patent owners
The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
Gift this article